Home/Filings/4/0001209191-05-012048
4//SEC Filing

MOMENTA PHARMACEUTICALS INC 4

Accession 0001209191-05-012048

CIK 0001235010operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:50 PM ET

Size

28.7 KB

Accession

0001209191-05-012048

Insider Transaction Report

Form 4
Period: 2005-02-22
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
SPOON ALAN G
10% Owner
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2005-02-22$7.02/sh240,150$1,685,8534,622,866 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh3,725$26,15072,923 total(indirect: See footnotes)
  • Sale

    Common Stock

    2005-02-22$7.02/sh6,125$42,998120,141 total(indirect: See footnotes)
Footnotes (6)
  • [F1]These shares are owned directly by Polaris Venture Partners Entrepreneurs' Fund III, L.P. ("PVPEF III"), of which Polaris Venture Management Co. III, LLC ("PVM III") is the General Partner. As such, PVM III may be deemed to share voting and investment powers with respect to the shares owned by PVPEF III.
  • [F2]These shares are owned directly by Polaris Venture Partners III, L.P. ("PVP III") of which PVM III is the General Partner. As such, PVM III may be deemed to share voting and investment powers with respect to the shares owned by PVP III.
  • [F3]These shares are owned directly by Polaris Venture Partners Founders' Fund III, L.P. ("PVPFF III"), of which PVM III is the General Partner. As such, PVM III may be deemed to share voting and investment powers with respect to the shares owned by PVPFF III.
  • [F4]PVM III is the General Partner of PVP III, PVPEF III and PVPFF III, and Stephen D. Arnold, Jonathan A. Flint, Terrance G. McGuire and Alan G. Spoon, the managing members of PVM III, may be deemed to share voting and dispositive power over the shares held by PVP III, PVPEF III and PVPFF III. Such persons disclaim beneficial ownership of shares held by PVP III, PVPEF III and PVPFF III except to the extent of any pecuniary interest therein.
  • [F5]North Star Ventures directly or indirectly provides investment advisory services to various venture capital funds, including PVM III, the General Partner of PVPEF III, PVPFF III and PVP III. The respective General Partners of these funds exercise sole voting and investment power with respect to the shares held by such funds.
  • [F6]Continued from footnote 5. The members of North Star Ventures are members of PVM III, the General Partner of PVPEF III, PVPFF III and PVP III. As members of PVM III, they may be deemed to share voting and investment powers with respect to the shares held by such funds. These principals disclaim beneficial ownership of all such shares except to the extent of their proportionate pecuniary interest therein.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001235010

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:50 PM ET
Size
28.7 KB